Yu Zhu

机构：Kunming University of Science and Technology, Shanghai Medical College of Fudan University, First People's Hospital of Yunnan Province, Fudan University Shanghai Cancer Center, The First Hospital of Kunming · ORCID：0000-0002-3332-5202

发表论文 106 篇 · 总被引 2736 次 · h-index 30

代表论文

Olverembatinib treatment in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (2024 · Annals of Hematology · 被引 14)
TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1 / PD‐L1 blockade response in urothelial carcinoma (2024 · The Journal of Pathology · 被引 13)
Integrating molecular subtype and CD8+ T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer (2024 · Cancer Immunology Immunotherapy · 被引 10)
CXCR6 expression predicts prognosis and immunotherapeutic benefit in muscle-invasive bladder cancer (2024 · Frontiers in Oncology · 被引 6)
POLQ identifies a better response subset to immunotherapy in muscle‐invasive bladder cancer with high PD‐L1 (2024 · Cancer Medicine · 被引 6)
Dysphagia in Head and Neck Cancer Patients: A Qualitative Meta‐Synthesis of Patient and Caregiver Experiences and Perspectives (2025 · Journal of Advanced Nursing · 被引 5)